Urinary tract infection caused by fluoroquinolone- and cephem-resistant Enterobacteriaceae

International Journal of Antimicrobial Agents

Volumn 28, Issue SUPPL. 1, 2006, Pages 10-13

  Muratani, Tetsuro ^a   Matsumoto, Tetsuro ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Bacterial resistance; Complicated urinary tract infection; Japan; Uncomplicated urinary tract infection; Urinary isolates; Urinary tract infection (UTI)

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFPODOXIME; CEPHEM; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN; FROPENEM; GENTAMICIN; IMIPENEM; ISEPAMICIN; LEVOFLOXACIN; MEROPENEM; MINOCYCLINE; NITROFURANTOIN; OUTER MEMBRANE PROTEIN F; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CEPHEM RESISTANT ENTEROBACTERIACEAE; CYSTITIS; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FLUROQUINOLONE RESISTANT ENTEROBACTERIACEAE; HUMAN; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; URINARY TRACT INFECTION;

BETA-LACTAM RESISTANCE; CEFTIZOXIME; CEPHALOSPORINS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FLUOROQUINOLONES; HUMANS; URINARY TRACT INFECTIONS;

EID: 33746762192     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.05.009     Document Type: Article

References (14)

1. Muratani T., and Matsumoto T. Bacterial resistance to antimicrobials in urinary isolates. Int J Antimicrob Agents 24 Suppl. 1 (2004) S28-S31
2. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother 51 (2003) 69-76
3. Lee S.J., Lee S.D., Cho I.R., Sim B.S., Lee J.G., Kim C.S., Kim M.E., Cho Y.H., and Woo Y.N. Antimicrobial susceptibility of uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: a multicentre study in 2002. Int J Antimicrob Agents 24 Suppl 1 (2004) S61-S64
4. Komp Lindgren P., Karlsson A., and Hughes D. Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. Antimicrob Agents Chemother 47 (2003) 3222-3232
5. Fralick J.A. Evidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli. J Bacteriol 178 (1996) 5803-5805
6. Cohen S.P., McMurry L.M., Hooper D.C., Wolfson J.S., and Levy S.B. Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob Agents Chemother 33 (1989) 1318-1325
7. Ishida H., Fuziwara H., Kaibori Y., Horiuchi T., Sato K., and Osada Y. Cloning of multidrug resistance gene pqrA from Proteus vulgaris. Antimicrob Agents Chemother 39 (1995) 453-457
8. Tran J.H., and Jacoby G.A. Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci USA 99 (2002) 5638-5642
9. Hata M., Suzuki M., Matsumoto M., et al. Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob Agents Chemother 49 (2005) 801-803
10. Wang M., Tran J.H., Jacoby G.A., Zhang Y., Wang F., and Hooper D.C. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother 47 (2003) 2242-2248
11. Rodriguez-Martinez J.M., Pascual A., Garcia I., and Martinez-Martinez L. Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type beta-lactamase. J Antimicrob Chemother 52 (2003) 703-706
12. Jacoby G.A., Chow N., and Waites K.B. Prevalence of plasmid-mediated quinolone resistance. Antimicrob Agents Chemother 47 (2003) 559-562
13. Winokur P.L., Canton R., Casellas J.M., and Legakis N. Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis 32 Suppl. 2 (2001) S94-S103
14. Bell J.M., Turnidge J.D., and Jones R.N. SENTRY Asia-Pacific Participants. Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program 1998 to 2001. Antimicrob Agents Chemother 47 (2003) 3989-3993